Market Tracker

07/31 9:09am ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

Thursday’s Trading Day
199.29 +0.53 / +0.27%
As of Jul 30
Day’s Change
Friday’s Pre-Market   Switch to standard view »
198.17 -1.12 / -0.56%
 
Volume: 120.00

Today’s Trading

Previous close198.76
Today’s open200.41
Day’s range-- - --
Volume2,578,733
Average volume (3 months)2,255,571
Market cap$44.9B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-5.57%
Earnings growth (next 5 years)+22.38%
Revenue growth (last year)+46.49%
P/E ratio68.3
Price/Sales16.84
Price/Book11.98

Competitors

 Today’s
change
Today’s
% change
SHPGShire-0.86-0.33%
VRTXVertex Pharmaceutica...+9.84+7.83%
PRGOPerrigo Company PLC-1.40-0.73%
MYLMylan NV-0.89-1.55%
Data as of 07/30/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.11
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts